Theravance Biopharma Inc Live Share Price Today, Share Analysis and Chart

Name: Theravance Biopharma Inc: Is Infosys Ltd. worth buying?
Item: Theravance Biopharma Inc
Rating: 1.689402875
Author: Trendlyne DVM scores

Momentum Trap

about

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient...

11.30 -0.16 (-1.40%)

Near 52W High of $11.82

179.1K

XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Low Financial Strength

27.8 / 100

Expensive Valuation

12.7 / 100

Technically Moderately Bullish

66.9 / 100

Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM

1Yr Price target upside is 52%

5 analysts

Theravance Biopharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Theravance Biopharma Inc Live Share Price Today, Share Analysis and Chart

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient...

Near 52W High of $11.82

SWOT Analysis

Theravance Biopharma Inc Live Price Chart